Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Carlos E. Salud has worked on the following 36 EPO patent applications which have been published in the last five years:

EP11711495

CYCLOPENTYL - AND CYCLOHEPTYLPYRAZOLES AS FXR MODULATORS

IPC classification:
A61K 31/416, A61K 31/4439, A61P 3/04, A61P 3/06, A61P 3/10, A61P 25/16, A61P 25/28, A61P 35/00, C07D 231/54, C07D 401/12, C07D 403/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11726127

3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-C]PYRROLES AS GLUCOKINASE ACTIVATORS

IPC classification:
A61K 31/407, A61P 3/10, C07D 491/052
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11730022

NEW AZACYCLIC COMPOUNDS

IPC classification:
A61K 31/435, A61P 3/00, C07D 471/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP11741230

NEW AZACYCLIC COMPOUNDS

IPC classification:
A61K 31/438, A61P 3/10, C07D 471/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11774034

GLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE ANALOGS

IPC classification:
A61P 3/00, C07K 14/605
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11776453

USE OF ACTIVE PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CONDITIONS

IPC classification:
A61K 31/4439, A61K 31/551, A61P 25/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11791572

NOVEL TRIAZOLE COMPOUNDS III

IPC classification:
A61K 31/4192, A61P 25/00, C07D 401/14, C07D 403/04, C07D 405/14, C07D 413/14, C07D 417/14, C07D 491/107
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11799718

NEW BIARYL AMIDE DERIVATIVES

IPC classification:
A61K 31/337, A61P 13/12, C07D 305/08, C07D 405/12, C07D 405/14, C07D 413/12, C07D 413/14, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12706050

NOVEL BENZODIOXOLE PIPERIDINE COMPOUNDS

IPC classification:
A61K 31/36, A61P 25/18, C07D 405/04, C07D 405/14, C07D 409/14, C07D 413/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12708335

NEW AZASPIRODECANONE COMPOUNDS

IPC classification:
A61K 31/403, A61P 3/00, C07D 209/54, C07D 401/04, C07D 401/08, C07D 401/14, C07D 403/08, C07D 491/107, C07D 491/113
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12708036

SEC-HYDROXYCYCLOHEXYL DERIVATIVES AS HSL INHIBITORS FOR THE TREATMENT DIABETES

IPC classification:
A61K 31/402, A61P 1/00, A61P 3/00, A61P 9/00, C07D 209/54
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12709886

NEW AZASPIRODECANONE COMPOUNDS AS HSL INHIBITORS

IPC classification:
A61K 31/403, A61K 31/4178, A61K 31/422, A61K 31/427, A61P 1/16, A61P 3/00, A61P 3/04, A61P 3/10, A61P 9/00, A61P 29/00, C07D 403/06, C07D 413/06, C07D 417/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12719356

NOVEL BENZOFURANE-PIPERIDINE COMPOUNDS

IPC classification:
A61K 31/343, A61K 31/4525, A61P 25/18, C07D 405/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12717736

ISOINDOLINONE DERIVATIVES

IPC classification:
A61K 31/4155, A61K 31/497, A61P 3/10, C07D 403/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12772789

SOLID FORMS OF 1,L-DIOXO-4-THIOMORPHOLINYL)-[6-[[3(4-FLUOROPHENYL)-5-METHYL-4-ISOXAZOLYL]METHOXY]-3-PYRIDINYL]-METHANONE

IPC classification:
A61K 31/541, A61P 25/28, C07D 401/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12772788

PROCESS FOR THE PREPARATION OF ISOXAZOLYL-METHOXY-NICOTINIC ACIDS

IPC classification:
C07D 413/12, C07D 413/14, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12713846

ANTI-FGFR4 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Genentech, Inc.
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12189107

Indol-amide compounds as beta-amyloid inhbitors

IPC classification:
A61K 31/404, A61K 31/454, A61K 31/497, A61P 25/00, C07D 401/04, C07D 401/06, C07D 401/14, C07D 403/04, C07D 403/06, C07D 405/04, C07D 405/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
APPLICATION REFUSED
EP13774129

CELL PENETRATING PEPTIDES WHICH BIND IRF5

IPC classification:
C07K 14/47
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13774418

MACROCYCLIC KETOAMIDE IMMUNOPROTEASOME INHIBITORS

IPC classification:
A61K 38/05, A61P 29/00, C07K 5/062, C07K 5/065
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13767013

KETOAMIDE IMMUNOPROTEASOME INHIBITORS

IPC classification:
A61P 29/00, C07K 5/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13798328

SUBSTITUTED TRIAZOLE BORONIC ACID COMPOUNDS

IPC classification:
A61K 31/69, A61P 29/00, C07F 5/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13799602

NOVEL BI-RING PHENYL-PYRIDINES/PYRAZINES FOR THE TREATMENT OF CANCER

IPC classification:
C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP11715201

AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS

IPC classification:
A61K 31/438, A61P 3/00, C07D 471/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14769665

POLYCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
A61K 31/4152, A61K 31/426, A61P 3/00, A61P 3/04, A61P 3/10, C07D 231/10, C07D 277/20
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14813526

AZETIDINE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
A61K 9/06, A61K 9/08, A61K 31/397, A61P 35/00
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14812952

ESTROGEN RECEPTOR MODULATOR AND USES THEREOF

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/397, A61P 35/00
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP11779633

Triazole derivatives as ligands for Gaba receptors

IPC classification:
A61K 31/4155, A61K 31/4192, A61K 31/427, A61P 25/28, C07D 403/12, C07D 405/14, C07D 413/14, C07D 417/06, C07D 417/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15154342

Compounds for the treatment of cancer

IPC classification:
A61K 31/433, A61K 31/435, A61K 31/4353, A61K 31/437, A61K 31/438, A61K 31/4436, A61K 31/454, A61K 31/4545, A61K 31/4709, A61K 31/501, A61K 31/502, A61K 31/506, A61K 31/5377, A61K 31/551, A61K 45/06, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
APPLICATION REFUSED
EP11727156

ANELLATED PYRIDINE COMPOUNDS AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS

IPC classification:
A61K 31/496, A61P 25/00, A61P 25/22, A61P 25/24, A61P 25/28, A61P 25/30, C07D 491/048, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11778911

TRIAZOLE DERIVATIVES AND THEIR USE FOR NEUROLOGICAL DISORDERS

IPC classification:
A61K 31/4192, A61K 31/4439, A61K 31/497, A61P 25/00, C07D 401/12, C07D 403/10, C07D 403/12, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 471/04, C07D 491/107
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11728862

(3-METHYLPYRROLIDIN-3-YL)METHYL PYRIDINYL ETHER DERIVATIVES AND THEIR USE AS NK-3 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4439, A61P 25/00, C07D 401/12, C07D 401/14, C07D 405/14, C07D 413/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15166641

SOLID FORMS

IPC classification:
C07C 209/62, C07C 209/84, C07C 211/36
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
APPLICATION PUBLISHED
EP14827261

ESTROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC ESTROGEN RECEPTOR POSITIVE BREAST CANCER

IPC classification:
A61K 31/416, A61P 35/00, A61P 35/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15709908

METHODS AND COMPOSITIONS FOR MODULATING ESTROGEN RECEPTOR MUTANTS

IPC classification:
A61K 31/397, A61K 31/4025, A61K 31/416, A61K 31/4245, A61K 31/428, A61K 31/5375
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15721701

COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY

IPC classification:
A61K 31/5025, A61P 21/00, C07D 487/04, C07D 519/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Carlos E. Salud, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature